Compare Organon & Co. Common Stock (OGN) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs SYSCO Corporation — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while SYSCO Corporation trades at $81.5 (market cap $38.88B). The key difference: SYSCO Corporation is far larger — about 10.7× Organon & Co. Common Stock's market cap, and SYSCO Corporation pays the higher dividend (2.78%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and SYSCO Corporation for 78 Days on average.
| OGN | SYY | |
|---|---|---|
Market Cap | $3.62B | $38.88B |
Volume | 2,892,999 | 2,477,462 |
Sector | Health | Consumer Staples |
52-Week High | $13.81 | $91.16 |
52-Week Low | $5.70 | $69.30 |
Typical Hold Time | 0 Days | 78 Days |
Enterprise Value | $11.04B | $52.06B |
Dividend Yield | 0.58% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
SYY trades at $80.97, up 2.88% with a bearish technical signal despite recent earnings beats. The company maintains steady revenue growth, reaching $81.37B in 2025, with strong profitability metrics including 78.16% ROE. Recent developments include a $500M AI efficiency program and a $1.5B senior notes offering. Analyst consensus remains positive with 60% buy ratings and an $85.75 price target, though technical indicators show resistance near $79-80 levels.
SYY presents a mixed outlook with strong fundamentals offset by technical weakness. The stock offers value with a 0.45 P/S ratio and dividend yield, supported by consistent revenue growth and AI-driven efficiency initiatives. Key risks include high debt levels at 49.75% debt-to-asset ratio and margin pressure as net income margin declined to 2.08%. Institutional ownership trends positive with recent pension fund increases.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
